缩写名/全名 |
BEHAV PHARMACOL
BEHAVIOURAL PHARMACOLOGY |
||||||||||||||||||||
ISSN号 | 0955-8810 | ||||||||||||||||||||
研究方向 | 医学-行为科学 | ||||||||||||||||||||
影响因子 | 2015:2, 2016:2.218, 2017:1.854, 2018:1.788, 2019:1.741, | ||||||||||||||||||||
出版国家 | UNITED STATES | ||||||||||||||||||||
出版周期 | Bimonthly | ||||||||||||||||||||
年文章数 | 75 | ||||||||||||||||||||
出版年份 | 1989 | ||||||||||||||||||||
是否OA | No | ||||||||||||||||||||
审稿周期(仅供参考) | 较慢,6-12周 |
||||||||||||||||||||
录用比例 | 较易 | ||||||||||||||||||||
投稿链接 | http://www.editorialmanager.com/bpharm/default.aspx | ||||||||||||||||||||
投稿官网 | http://journals.lww.com/behaviouralpharm/pages/default.aspx | ||||||||||||||||||||
h-index | 76 | ||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0955-8810%5BISSN%5D | ||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Neuroprotective effects of Danshensu in Parkinson's disease mouse model induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Author: Han B1, Che X2, Zhao Y1, Li C2, He J1, Lu Y1, Wang Z1, Wang T2. Journal: Behav Pharmacol. 2019 Feb;30(1):36-44. doi: 10.1097/FBP.0000000000000412. PubMed DOI |
2. | Chronic clozapine treatment improves the alterations of prepulse inhibition and BDNF mRNA expression in the medial prefrontal cortex that are induced by adolescent social isolation. Author: Li M1,2,3, Wang W4, Sun L5, Du W5, Zhou H5, Shao F5. Journal: Behav Pharmacol. 2019 Jun;30(4):311-319. doi: 10.1097/FBP.0000000000000419. PubMed DOI |
3. | A further assessment of a role for Toll-like receptor 4 in the reinforcing and reinstating effects of opioids. Author: Yue K1,2, Tanda G3, Katz JL1, Zanettini C1,3. Journal: Behav Pharmacol. 2019 Feb 7. doi: 10.1097/FBP.0000000000000474. [Epub ahead of print] PubMed DOI |
4. | Effects of N-ethylpentylone on locomotor activity and anxiety-like behavior in rats. Author: Li J1, Lin Z1, Tao X1, Huang Z1, Zhang Y2, Zheng S2, Wang H1, Rao Y1. Journal: Behav Pharmacol. 2019 Apr 26. doi: 10.1097/FBP.0000000000000484. [Epub ahead of print] PubMed DOI |
5. | From genetic studies to precision medicine in alcohol dependence. Author: Sun Y, Zhang Y, Wang F, Sun Y, Shi J, Lu L. Journal: Behav Pharmacol. 2016 Apr;27(2-3 Spec Issue):87-99. doi: 10.1097/FBP.0000000000000202. PubMed |
6. | Antinociceptive effects of imidazoline I2 receptor agonists in the formalin test in rats. Author: Thorn DA, Qiu Y, Jia S, Zhang Y, Li JX. Journal: Behav Pharmacol. 2016 Jun;27(4):377-83. doi: 10.1097/FBP.0000000000000206. PubMed |
7. | Effects of nucleus accumbens oxytocin and its antagonist on social approach behavior. Author: Yu CJ, Zhang SW, Tai FD. Journal: Behav Pharmacol. 2016 Mar 9. [Epub ahead of print] PubMed |
8. | GM1 ganglioside reverses the cognitive deficits induced by MK801 in mice. Author: Ni YF, Zhang W, Bao XF, Wang W, Song L, Jiang B. Journal: Behav Pharmacol. 2016 Aug;27(5):451-9. doi: 10.1097/FBP.0000000000000229. PubMed |
9. | Agmatine attenuates the discriminative stimulus and hyperthermic effects of methamphetamine in male rats. Author: Thorn DA, Li J, Qiu Y, Li JX. Journal: Behav Pharmacol. 2016 May 26. [Epub ahead of print] PubMed |
10. | Contextual and behavioral control of antipsychotic sensitization induced by haloperidol and olanzapine. Author: Zhang C, Li M. Journal: Behav Pharmacol. 2012 Feb;23(1):66-79. doi: 10.1097/FBP.0b013e32834ecac4. PubMed |
|
|